Compile Data Set for Download or QSAR
maximum 50k data
Found 29 Enz. Inhib. hit(s) with all data for entry = 50003110
TargetArsenite methyltransferase(Homo sapiens)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50467094(CHEMBL4281164)
Affinity DataIC50:  1.40E+3nMAssay Description:Inhibition of human AS3MT using NaAsO2 as substrate preincubated for 30 minutes followed by substrate addition measured after 90 mins in presence of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetArsenite methyltransferase(Homo sapiens)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50467089(CHEMBL4295161)
Affinity DataIC50:  1.50E+3nMAssay Description:Inhibition of human AS3MT using NaAsO2 as substrate preincubated for 30 minutes followed by substrate addition measured after 90 mins in presence of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetArsenite methyltransferase(Homo sapiens)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50082133(CHEMBL3422652)
Affinity DataIC50:  1.80E+3nMAssay Description:Inhibition of human AS3MT using NaAsO2 as substrate preincubated for 30 minutes followed by substrate addition measured after 90 mins in presence of ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetArsenite methyltransferase(Homo sapiens)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50467091(CHEMBL4287966)
Affinity DataIC50:  2.90E+3nMAssay Description:Inhibition of human AS3MT using NaAsO2 as substrate preincubated for 30 minutes followed by substrate addition measured after 90 mins in presence of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetArsenite methyltransferase(Homo sapiens)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50082128(CHEMBL3422654)
Affinity DataIC50:  3.00E+3nMAssay Description:Inhibition of human AS3MT using NaAsO2 as substrate preincubated for 30 minutes followed by substrate addition measured after 90 mins in presence of ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetArsenite methyltransferase(Homo sapiens)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50082132(CHEMBL3422653)
Affinity DataIC50:  3.30E+3nMAssay Description:Inhibition of human AS3MT using NaAsO2 as substrate preincubated for 30 minutes followed by substrate addition measured after 90 mins in presence of ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetArsenite methyltransferase(Homo sapiens)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50467088(CHEMBL4280063)
Affinity DataIC50:  3.60E+3nMAssay Description:Inhibition of human AS3MT using NaAsO2 as substrate preincubated for 30 minutes followed by substrate addition measured after 90 mins in presence of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetArsenite methyltransferase(Homo sapiens)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50082129(CHEMBL3421643)
Affinity DataIC50:  5.00E+3nMAssay Description:Inhibition of human AS3MT using NaAsO2 as substrate preincubated for 30 minutes followed by substrate addition measured after 90 mins in presence of ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistone-lysine N-methyltransferase NSD2(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50467089(CHEMBL4295161)
Affinity DataIC50:  5.80E+3nMAssay Description:Inhibition of full-length NSD2 (unknown origin) using HeLa oligonucleosome as substrate preincubated for 15 mins followed by substrate addition measu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetArsenite methyltransferase(Homo sapiens)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50082136(CHEMBL3422659)
Affinity DataIC50:  8.30E+3nMAssay Description:Inhibition of human AS3MT using NaAsO2 as substrate preincubated for 30 minutes followed by substrate addition measured after 90 mins in presence of ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistone-lysine N-methyltransferase NSD2(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50082129(CHEMBL3421643)
Affinity DataIC50:  9.10E+3nMAssay Description:Inhibition of full-length NSD2 (unknown origin) using HeLa oligonucleosome as substrate preincubated for 15 mins followed by substrate addition measu...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistone-lysine N-methyltransferase NSD2(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50082128(CHEMBL3422654)
Affinity DataIC50:  1.10E+4nMAssay Description:Inhibition of full-length NSD2 (unknown origin) using HeLa oligonucleosome as substrate preincubated for 15 mins followed by substrate addition measu...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistone-lysine N-methyltransferase NSD2(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50082133(CHEMBL3422652)
Affinity DataIC50:  1.20E+4nMAssay Description:Inhibition of full-length NSD2 (unknown origin) using HeLa oligonucleosome as substrate preincubated for 15 mins followed by substrate addition measu...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetArsenite methyltransferase(Homo sapiens)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50467092(CHEMBL4284586)
Affinity DataIC50:  1.36E+4nMAssay Description:Inhibition of human AS3MT using NaAsO2 as substrate preincubated for 30 minutes followed by substrate addition measured after 90 mins in presence of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetArsenite methyltransferase(Homo sapiens)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50467090(CHEMBL4279997)
Affinity DataIC50:  2.00E+4nMAssay Description:Inhibition of human AS3MT using NaAsO2 as substrate preincubated for 30 minutes followed by substrate addition measured after 90 mins in presence of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetHistone-lysine N-methyltransferase NSD2(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50082132(CHEMBL3422653)
Affinity DataIC50:  4.70E+4nMAssay Description:Inhibition of full-length NSD2 (unknown origin) using HeLa oligonucleosome as substrate preincubated for 15 mins followed by substrate addition measu...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistone-lysine N-methyltransferase NSD2(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50467088(CHEMBL4280063)
Affinity DataIC50:  4.90E+4nMAssay Description:Inhibition of full-length NSD2 (unknown origin) using HeLa oligonucleosome as substrate preincubated for 15 mins followed by substrate addition measu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetHistone-lysine N-methyltransferase, H3 lysine-79 specific(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50467089(CHEMBL4295161)
Affinity DataIC50:  9.60E+4nMAssay Description:Inhibition of full-length DOT1L (unknown origin) using HeLa oligonucleosome as substrate preincubated for 15 mins followed by substrate addition meas...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetHistone-lysine N-methyltransferase, H3 lysine-79 specific(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50082133(CHEMBL3422652)
Affinity DataIC50:  9.90E+4nMAssay Description:Inhibition of full-length DOT1L (unknown origin) using HeLa oligonucleosome as substrate preincubated for 15 mins followed by substrate addition meas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetArsenite methyltransferase(Homo sapiens)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50082138(CHEMBL3422661)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of human AS3MT using NaAsO2 as substrate preincubated for 30 minutes followed by substrate addition measured after 90 mins in presence of ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistone-lysine N-methyltransferase NSD2(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50467092(CHEMBL4284586)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of full-length NSD2 (unknown origin) using HeLa oligonucleosome as substrate preincubated for 15 mins followed by substrate addition measu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetHistone-lysine N-methyltransferase, H3 lysine-79 specific(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50082132(CHEMBL3422653)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of full-length DOT1L (unknown origin) using HeLa oligonucleosome as substrate preincubated for 15 mins followed by substrate addition meas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistone-lysine N-methyltransferase, H3 lysine-79 specific(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50467088(CHEMBL4280063)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of full-length DOT1L (unknown origin) using HeLa oligonucleosome as substrate preincubated for 15 mins followed by substrate addition meas...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetHistone-lysine N-methyltransferase NSD2(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50467094(CHEMBL4281164)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of full-length NSD2 (unknown origin) using HeLa oligonucleosome as substrate preincubated for 15 mins followed by substrate addition measu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetHistone-lysine N-methyltransferase, H3 lysine-79 specific(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50082128(CHEMBL3422654)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of full-length DOT1L (unknown origin) using HeLa oligonucleosome as substrate preincubated for 15 mins followed by substrate addition meas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistone-lysine N-methyltransferase, H3 lysine-79 specific(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50082129(CHEMBL3421643)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of full-length DOT1L (unknown origin) using HeLa oligonucleosome as substrate preincubated for 15 mins followed by substrate addition meas...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistone-lysine N-methyltransferase, H3 lysine-79 specific(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50467094(CHEMBL4281164)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of full-length DOT1L (unknown origin) using HeLa oligonucleosome as substrate preincubated for 15 mins followed by substrate addition meas...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetHistone-lysine N-methyltransferase, H3 lysine-79 specific(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50467092(CHEMBL4284586)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of full-length DOT1L (unknown origin) using HeLa oligonucleosome as substrate preincubated for 15 mins followed by substrate addition meas...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetArsenite methyltransferase(Homo sapiens)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50467093(CHEMBL4295236)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of human AS3MT using NaAsO2 as substrate preincubated for 30 minutes followed by substrate addition measured after 90 mins in presence of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed